BioSig Technologies, Inc.·4

Dec 20, 9:56 PM ET

ODONNELL JEFFREY F 4

4 · BioSig Technologies, Inc. · Filed Dec 20, 2019

Insider Transaction Report

Form 4
Period: 2019-12-18
Transactions
  • Exercise/Conversion

    Common Stock

    2019-12-18$5.23/sh+38,320$200,414257,695 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-12-18+38,3200 total
    Exercise: $5.23Exp: 2020-01-01Common Stock (38,320 underlying)
  • Tax Payment

    Common Stock

    2019-12-18$6.45/sh31,066$200,376226,629 total
Footnotes (2)
  • [F1]This price represents the average of the high and low trading prices of the Issuer's common stock on December 17, 2019.
  • [F2]The options vested in 12 consecutive monthly installments beginning one month from January 1, 2013, the date of the grant. As of the date of this report, the options are vested and exercisable as to all 38,320 underlying shares.

Documents

1 file
  • 4
    ownership.xmlPrimary